Added to YB: 2023-04-03
Pitch date: 2023-04-03
PRDS [bullish]
Pardes Biosciences, Inc.
+58.82%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to treat and prevent viral diseases.
Market Cap
$131.2M
Pitch Price
$1.36
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-1.69
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Pardes Biosciences: Failed Biotech/SPAC, Trading Below Cash
A summary for this pitch has not been created yet.
Read full article (1 min)